Development of a novel risk model to predict CRPC progression following IMRT: Implications for tailoring treatment intensity
This RS model provided useful information to enable tailoring of the treatment intensity for this heterogeneous population.
Authors
- Kiyonao Nakamura (ORCID: https://orcid.org/0000-0001-8660-4363)
- Takashi Kobayashi (ORCID: https://orcid.org/0000-0003-1069-2816)
- Takashi Mizowaki (ORCID: https://orcid.org/0000-0002-8135-8746)
- Yuki Kita (ORCID: https://orcid.org/0000-0002-6942-9695)
- Rihito Aizawa (ORCID: https://orcid.org/0000-0001-7098-6221)
- Hiroyasu Abe
- Kei Mizuno (ORCID: https://orcid.org/0000-0002-1273-5288)
- Takayuki Sumiyoshi (ORCID: https://orcid.org/0000-0001-5321-6014)
- Takayuki Goto (ORCID: https://orcid.org/0000-0001-6537-3068)
- Satoshi Morita (ORCID: https://orcid.org/0000-0001-5372-7113)
- Kaoru Murakami (ORCID: https://orcid.org/0000-0002-4226-3867)
- Takashi Ogata
Institutions
- Kyoto University (JP)
- Kyoto City Hospital (JP)
Publication Details
- Journal
- BJUI Compass
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1002/bco2.70074
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Society for the Promotion of Science